![Jay Green](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 126 $ al 30/06/2026
Jay Green currently works at Scinai Immunotherapeutics Ltd., as Independent Director from 2021.
Mr. Green also formerly worked at GSK Plc, as Senior Vice President-Finance from 2014 to 2020.
Mr. Green received his graduate degree from The University of Waterloo.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 200.000 ( 0 % ) | 126 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Director/Miembro de la Junta | 27/12/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/12/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scinai Immunotherapeutics Ltd.
 Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
